RESEARCH-USE BIOSIMILAR ANTIBODY

Laprituximab

Antibody-drug conjugate · IgG1

EGFRIgG1RUO

Laprituximab (J2898A) is a humanized IgG1 anti-EGFR antibody that can be used for the synthesis of ADC IMGN289.

TARGETEGFR
YAntibody-drug conjugate
CATALOGSC-BS-448
CATALOG NUMBERSC-BS-448
MOLECULAR WEIGHTApprox. 145.2 kDa
PRODUCT FORMATAntibody-drug conjugate

A research-use configuration for comparative antibody studies

Laprituximab (J2898A) is a humanized IgG1 anti-EGFR antibody that can be used for the synthesis of ADC IMGN289.

Laprituximab is a recombinant research-use antibody directed against EGFR.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte